Sarcoma
Showing NaN - NaN of 133
Early Psychiatric Referral on Mental Health and Quality of Life
Recruiting
- Sarcoma
- +2 more
- referral to the Memorial Sloan-Kettering Cancer Center (MSK) Department of Psychiatry and Behavioral Sciences.
-
Basking Ridge, New Jersey
- +7 more
Nov 10, 2023
A Study of Immunotherapy Treatment in People With Sarcoma
Enrolling by invitation
- Sarcoma
-
Basking Ridge, New Jersey
- +6 more
Oct 27, 2023
Dedifferentiated Liposarcoma, Soft Tissue Sarcoma, Sarcoma,Soft Tissue Trial in United States (Etrumadenant, Zimberelimab)
Recruiting
- Dedifferentiated Liposarcoma
- +6 more
-
Basking Ridge, New Jersey
- +6 more
May 23, 2023
Sarcoma Trial in United States (XmAb23104)
Recruiting
- Sarcoma
- XmAb23104
-
Basking Ridge, New Jersey
- +6 more
May 18, 2023
Invasive Ductal Breast Carcinoma, Invasive Ductal Breast Carcinoma Stage IV, Lobular Breast Carcinoma Trial in United States
Recruiting
- Invasive Ductal Breast Carcinoma
- +14 more
- Stereotactic body radiotherapy
- Lattice Radiation Therapy
-
Basking Ridge, New Jersey
- +6 more
Apr 20, 2023
Sarcoma, Epithelioid Sarcoma, Cutaneous Angiosarcoma Trial in Stanford, New York (Talimogene Laherparepvec (T-VEC),
Recruiting
- Sarcoma
- +2 more
- Talimogene Laherparepvec (T-VEC)
- Pembrolizumab
-
Stanford, California
- +1 more
Feb 2, 2023
Ovarian Cancer, Cervical Cancer, Endometrial Cancer Trial in Worldwide (Enapotamab vedotin (HuMax-AXL-ADC))
Completed
- Ovarian Cancer
- +7 more
- Enapotamab vedotin (HuMax-AXL-ADC)
-
Phoenix, Arizona
- +40 more
Dec 12, 2022
Genomic Structural Variation in Cancer Susceptibility
Active, not recruiting
- Breast Cancer
- +5 more
-
New York, New YorkMemorial Sloan Kettering Cancer Center
Dec 23, 2022
Clinical Stage I Cutaneous Melanoma AJCC v8, Clinical Stage IA Cutaneous Melanoma AJCC v8, Clinical Stage IB Cutaneous Melanoma
Recruiting
- Clinical Stage I Cutaneous Melanoma AJCC v8
- +33 more
- Informational Intervention
- +4 more
-
Los Angeles, California
- +4 more
Dec 14, 2022
Melanoma, Neuroblastoma, Sarcoma Trial in New York (124I-Humanized 3F8)
Active, not recruiting
- Melanoma
- +2 more
- 124I-Humanized 3F8
-
New York, New YorkMemorial Sloan Kettering Cancer Center
Dec 1, 2022
Sarcoma, Myxofibrosarcoma, Undifferentiated Pleomorphic Sarcoma Trial in United States (Isolated Limb Infusion, Pembrolizumab,
Recruiting
- Sarcoma
- +3 more
- Isolated Limb Infusion
- +2 more
-
Basking Ridge, New Jersey
- +6 more
Nov 21, 2022
Renal Cell Cancer, Melanoma, Non-Small-Cell Lung Cancer Trial in Duarte, Louisville, New York (PF-07263689, Sasanlimab)
Active, not recruiting
- Renal Cell Cancer
- +9 more
- PF-07263689
- Sasanlimab
-
Duarte, California
- +5 more
Nov 8, 2022
Hepatocellular Carcinoma, Metastatic Castration Resistant Prostate Cancer, Renal Cell Carcinoma Trial in United States (Part 1
Active, not recruiting
- Hepatocellular Carcinoma
- +11 more
- Part 1 TPST-1120
- +3 more
-
San Francisco, California
- +10 more
Nov 1, 2022
Melanoma, Ovarian Cancer, Sarcoma Trial in Italy, Portugal, United States (IGIMRT using a single dose of 24 Gy, IGIMRT 27 Gy in
Active, not recruiting
- Melanoma
- +6 more
- IGIMRT using a single dose of 24 Gy
- IGIMRT 27 Gy in 3 fractions
-
San Francisco, California
- +3 more
Nov 1, 2022
Prostate Cancer, Bladder Cancer, NSCLC Trial in New York, Houston (NY-ESO-1 Plasmid DNA Cancer Vaccine)
Completed
- Prostate Cancer
- +4 more
- NY-ESO-1 Plasmid DNA Cancer Vaccine
-
New York, New York
- +1 more
Oct 3, 2022
Sarcoma, Dedifferentiated Liposarcoma Trial in New York (Abemaciclib)
Active, not recruiting
- Sarcoma
- Dedifferentiated Liposarcoma
-
New York, New YorkMemorial Sloan Kettering Cancer Center
Aug 17, 2022
NSCLC, Renal Cell Cancer, Colorectal Cancer Trial in Australia, United States (CPI-006, CPI-006 + ciforadenant, CPI-006 +
Active, not recruiting
- Non-Small Cell Lung Cancer
- +12 more
- CPI-006
- +2 more
-
Tucson, Arizona
- +26 more
Aug 1, 2022
Breast Cancer, Head Neck Cancer, Squamous Cell Carcinoma Trial in Canada, United States (INT230-6, anti-PD-1 antibody,
Active, not recruiting
- Breast Cancer
- +10 more
- INT230-6
- +2 more
-
Los Angeles, California
- +7 more
Jun 21, 2022